FDAFDA · Food and drugs·Recall number D-1254-2020
Tetracycline HCL Capsules, USP, 500 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-018-01
Published April 15, 2020 · Recall initiated: March 23, 2020
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- TETRACYCLINE HYDROCHLORIDE
- Manufacturer
- Avet Pharmaceuticals, Inc.
- Distributor
- Distributed Nationwide in the US
- UPC
- 0323155017014
- Lot
- Lot #s: G190609, G190610, G190611, Exp Jun 2022: L191027, L191028, Exp Nov 2022: K190953, K190952, Exp Oct 2022
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.